BUNKER KEVIN D. (Chief Operating Officer) sold 4.3% of their position (10K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $759.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/23/2021ACC: 0001725160-21-000228
Officer· Chief Operating Officer
Since Apr 2020
-10K
Net shares
Net seller
$759.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−10K
Price / share
$75.99
Trade value
$759.94K
% of position
4.3%
11/22/2021
230K→220K
Total
Net shares
−10K
Net value
-$759.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/22/2021 | S · Sale | −10K | $75.99 | $759.94K | 4.3% | 230K | 220K |
| Total | −10K | -$759.94K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned350.00
Common Stock
DirectShares owned755.07K
Total
755.07K direct·350.00 indirect755.42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 350.00 | Indirect |
| Common Stock | 755.07K | Direct |
| Total | 755.42K | 755.07K direct·350.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported